Valuation: Guerbet

Market Cap 78.54M 87.53M 72.61M 65.76M 123M 8.34B 124M 868M 346M 4.36B 328M 322M 13.85B P/E 2026 *
-4.97x
P/E 2027 * 5.97x
Enterprise Value 456M 508M 421M 382M 713M 48.39B 722M 5.04B 2.01B 25.32B 1.91B 1.87B 80.38B EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.56x
Free-Float
36.58%
Yield 2026 *
2.66%
Yield 2027 * 3.73%
1 day+4.68%
1 week+7.75%
Current month-10.57%
1 month-11.21%
3 months-16.76%
6 months-47.39%
Current year-56.22%
1 week 5.88
Extreme 5.88
6.26
1 month 5.8
Extreme 5.8
7.03
Current year 5.8
Extreme 5.8
15.12
1 year 5.8
Extreme 5.8
18.26
3 years 5.8
Extreme 5.8
40.25
5 years 5.8
Extreme 5.8
40.25
10 years 5.8
Extreme 5.8
90.64
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 65 23/05/2025
Director/Board Member 63 19/05/2011
Director/Board Member 56 29/06/2010
Date Insider Type Main position Quantity % Market Cap. Importance
6/8/26 Buy

Director

1,185 0.0094%
5/8/26 Buy

Director

5,027 0.0398%
4/8/26 Buy

Director

3,788 0.0300%
Change 5-day change 1-year change 3-year change Capi.($)
+4.68%+7.75%-61.02%-62.87% 83.59M
+1.61%+1.46%+26.28%+63.22% 256B
+0.89%+0.09%+7.92%+24.58% 163B
-0.38%+3.75%-18.56%+71.51% 155B
-5.84%-4.67%-57.98%-14.32% 65.3B
+1.06%+3.82%+11.67%+48.73% 52.35B
+1.72%+2.11%-12.83%-7.13% 51.93B
+1.39%-0.85%+9.09%+67.70% 50.75B
+2.25%+2.10%+24.43%+76.59% 50.04B
+1.78%+4.24%+37.85%+94.84% 46.03B
Average +0.92%+1.72%-3.32%+36.28% 89.05B
Weighted average by Cap. +0.59%+1.68%+5.32%+49.57%

Financials

2026 *2027 *
Net sales 767M 854M 709M 642M 1.2B 81.37B 1.21B 8.47B 3.37B 42.58B 3.21B 3.14B 135B 801M 893M 740M 671M 1.25B 85.02B 1.27B 8.85B 3.53B 44.49B 3.35B 3.28B 141B
Net income -51.5M -57.4M -47.61M -43.12M -80.56M -5.47B -81.54M -569M -227M -2.86B -215M -211M -9.08B 8.2M 9.14M 7.58M 6.87M 12.83M 870M 12.98M 90.64M 36.1M 455M 34.3M 33.57M 1.45B
Net Debt 377M 420M 349M 316M 590M 40.05B 597M 4.17B 1.66B 20.96B 1.58B 1.54B 66.53B 373M 415M 345M 312M 583M 39.56B 590M 4.12B 1.64B 20.7B 1.56B 1.53B 65.71B
Projected Income Statement - Annual - Guerbet
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
28/10/26 EUR 6.260 +4.68% 15,941
27/10/26 EUR 5.980 +0.34% 7,268
26/10/26 EUR 5.960 -0.50% 14,436
23/10/26 EUR 5.990 -0.83% 3,126
22/10/26 EUR 6.040 +3.96% 20,588
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Guerbet
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
6.260EUR
Average target price
7.767EUR
Spread / Average Target
+24.07%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Guerbet